Amit Hasija
Finanzdirektor/CFO bei MILESTONE PHARMACEUTICALS INC.
Vermögen: 30 342 $ am 30.04.2024
Aktive Positionen von Amit Hasija
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Finanzdirektor/CFO | 09.09.2019 | - |
Milestone Pharmaceuticals USA, Inc.
 Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Treasurer | - | - |
Karriereverlauf von Amit Hasija
Ehemalige bekannte Positionen von Amit Hasija
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.03.2017 | 01.01.2019 |
| SANOFI | Corporate Officer/Principal | 01.10.2012 | 01.01.2017 |
| MERCK & CO., INC. | Geschäftsführer | 01.01.1995 | 01.01.2000 |
Ausbildung von Amit Hasija
| Drexel University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 6 |
| Frankreich | 2 |
| Kanada | 2 |
Operativ
| Director of Finance/CFO | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SANOFI | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Milestone Pharmaceuticals USA, Inc.
Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Health Technology |
- Börse
- Insiders
- Amit Hasija
- Erfahrung
